164 related articles for article (PubMed ID: 31834527)
1. Economic impacts of care by high-volume providers for non-curative esophagogastric cancer: a population-based analysis.
Hallet J; Look Hong NJ; Zuk V; Davis LE; Gupta V; Earle CC; Mittmann N; Coburn NG
Gastric Cancer; 2020 May; 23(3):373-381. PubMed ID: 31834527
[TBL] [Abstract][Full Text] [Related]
2. Variation in receipt of therapy and survival with provider volume for medical oncology in non-curative esophago-gastric cancer: a population-based analysis.
Hallet J; Davis LE; Mahar AL; Liu Y; Zuk V; Gupta V; Earle CC; Coburn NG
Gastric Cancer; 2020 Mar; 23(2):300-309. PubMed ID: 31628561
[TBL] [Abstract][Full Text] [Related]
3. Patient education-level affects treatment allocation and prognosis in esophageal- and gastroesophageal junctional cancer in Sweden.
Linder G; Sandin F; Johansson J; Lindblad M; Lundell L; Hedberg J
Cancer Epidemiol; 2018 Feb; 52():91-98. PubMed ID: 29278841
[TBL] [Abstract][Full Text] [Related]
4. Geographic impact on access to care and survival for non-curative esophagogastric cancer: a population-based study.
Yee EK; Coburn NG; Zuk V; Davis LE; Mahar AL; Liu Y; Gupta V; Darling G; Hallet J
Gastric Cancer; 2021 Jul; 24(4):790-799. PubMed ID: 33550518
[TBL] [Abstract][Full Text] [Related]
5. Patient, nursing and medical staff experiences and perceptions of the care of people with palliative esophagogastric cancer: a systematic review of the qualitative evidence.
Cowley A; Evans C; Bath-Hextall F; Cooper J
JBI Database System Rev Implement Rep; 2016 Oct; 14(10):134-166. PubMed ID: 27846123
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of superficial neoplasia at the esophagogastric junction treated via endoscopic submucosal dissection and endoscopic submucosal tunnel dissection: a cohort study of a single center from China.
Liu S; Chai N; Lu Z; Li H; Xiong Y; Zhai Y; Linghu E
Surg Endosc; 2020 Jan; 34(1):216-225. PubMed ID: 30993514
[TBL] [Abstract][Full Text] [Related]
7. Impact of multidisciplinary tumor board discussion on palliation of patients with esophageal or gastro-esophageal junction cancer: a population-based study.
Vermeulen BD; Bruggeman L; Bac DJ; Schrauwen RWM; Epping LSM; Scheffer RCH; Tan ACITL; Groenen MJM; Verhoeven RHA; Siersema PD
Acta Oncol; 2020 Apr; 59(4):410-416. PubMed ID: 32067535
[No Abstract] [Full Text] [Related]
8. Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach?
Heger U; Blank S; Wiecha C; Langer R; Weichert W; Lordick F; Bruckner T; Dobritz M; Burian M; Springfeld C; Grenacher L; Siewert JR; Büchler M; Ott K
Ann Surg Oncol; 2014 May; 21(5):1739-48. PubMed ID: 24419755
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric Cancer.
Greally M; Chou JF; Chatila WK; Margolis M; Capanu M; Hechtman JF; Tuvy Y; Kundra R; Daian F; Ladanyi M; Kelsen DP; Ilson DH; Berger MF; Tang LH; Solit DB; Diaz LA; Schultz N; Janjigian YY; Ku GY
Clin Cancer Res; 2019 Oct; 25(20):6160-6169. PubMed ID: 31337644
[TBL] [Abstract][Full Text] [Related]
10. Early Interdisciplinary Supportive Care in Patients With Previously Untreated Metastatic Esophagogastric Cancer: A Phase III Randomized Controlled Trial.
Lu Z; Fang Y; Liu C; Zhang X; Xin X; He Y; Cao Y; Jiao X; Sun T; Pang Y; Wang Y; Zhou J; Qi C; Gong J; Wang X; Li J; Tang L; Shen L
J Clin Oncol; 2021 Mar; 39(7):748-756. PubMed ID: 33417481
[TBL] [Abstract][Full Text] [Related]
11. Comparison between gastric and esophageal classification system among adenocarcinomas of esophagogastric junction according to AJCC 8th edition: a retrospective observational study from two high-volume institutions in China.
Liu K; Feng F; Chen XZ; Zhou XY; Zhang JY; Chen XL; Zhang WH; Yang K; Zhang B; Zhang HW; Zhou ZG; Hu JK
Gastric Cancer; 2019 May; 22(3):506-517. PubMed ID: 30390154
[TBL] [Abstract][Full Text] [Related]
12. A reliable risk score for stage IV esophagogastric cancer.
Blank S; Lordick F; Dobritz M; Grenacher L; Burian M; Langer R; Roth W; Schaible A; Becker K; Bläker H; Sisic L; Stange A; Compani P; Schulze-Bergkamen H; Jäger D; Büchler M; Siewert JR; Ott K
Eur J Surg Oncol; 2013 Aug; 39(8):823-30. PubMed ID: 23375470
[TBL] [Abstract][Full Text] [Related]
13. Role of repeat staging laparoscopy in locoregionally advanced gastric or gastroesophageal cancer after neoadjuvant therapy.
Cardona K; Zhou Q; Gönen M; Shah MA; Strong VE; Brennan MF; Coit DG
Ann Surg Oncol; 2013 Feb; 20(2):548-54. PubMed ID: 22941159
[TBL] [Abstract][Full Text] [Related]
14. [Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].
Amato L; Colais P; Davoli M; Ferroni E; Fusco D; Minozzi S; Moirano F; Sciattella P; Vecchi S; Ventura M; Perucci CA
Epidemiol Prev; 2013; 37(2-3 Suppl 2):1-100. PubMed ID: 23851286
[TBL] [Abstract][Full Text] [Related]
15. Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Büyükkaramikli NC; Blommestein HM; Riemsma R; Armstrong N; Clay FJ; Ross J; Worthy G; Severens J; Kleijnen J; Al MJ
Pharmacoeconomics; 2017 Dec; 35(12):1211-1221. PubMed ID: 28656543
[TBL] [Abstract][Full Text] [Related]
16. Gastrectomy case volume and textbook outcome: an analysis of the Population Registry of Esophageal and Stomach Tumours of Ontario (PRESTO).
Levy J; Gupta V; Amirazodi E; Allen-Ayodabo C; Jivraj N; Jeong Y; Davis LE; Mahar AL; De Mestral C; Saarela O; Coburn N;
Gastric Cancer; 2020 May; 23(3):391-402. PubMed ID: 31686260
[TBL] [Abstract][Full Text] [Related]
17. A rationale multidisciplinary approach for treatment of esophageal and gastroesophageal junction cancer: Accurate review of management and perspectives.
Chiappa A; Andreoni B; Dionigi R; Spaggiari L; Foschi D; Polvani G; Orecchia R; Fazio N; Pravettoni G; Cossu ML; Galetta D; Venturino M; Ferrari C; Macone L; Crosta C; Bonanni B; Biffi R
Crit Rev Oncol Hematol; 2018 Dec; 132():161-168. PubMed ID: 30447922
[TBL] [Abstract][Full Text] [Related]
18. Dedicated Perioperative Hip Fracture Comanagement Programs are Cost-effective in High-volume Centers: An Economic Analysis.
Swart E; Vasudeva E; Makhni EC; Macaulay W; Bozic KJ
Clin Orthop Relat Res; 2016 Jan; 474(1):222-33. PubMed ID: 26260393
[TBL] [Abstract][Full Text] [Related]
19. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
Mortensen MB
Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
[TBL] [Abstract][Full Text] [Related]
20. Association between provider volume and healthcare expenditures of patients with oral cancer in Taiwan: a population-based study.
Chen LF; Ho HC; Su YC; Lee MS; Hung SK; Chou P; Lee CC; Lin LC; Lee CC
PLoS One; 2013; 8(6):e65077. PubMed ID: 23750234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
